Literature DB >> 24496015

Synthesis of Fmoc-Gly-Ile Phosphinic Pseudodipeptide: Residue Specific Conditions for Construction of Matrix Metalloproteinase Inhibitor Building Blocks.

Manishabrata Bhowmick1, Gregg B Fields1.   

Abstract

The efficient synthesis of an Fmoc-Gly-Ile phosphinic pseudodipeptide was desired as an eventual building block for construction of matrix metalloproteinase inhibitors. A Michael-type addition reaction of bis(tri-methylsilyl) phosphonite with the appropriate acrylate generated the pseudodipeptide bond. Additional of adamantyl (Ad) protection by our prior route (reaction of in situ generated phosphinic acid chloride with the sodium salt of adamantanol) was surprisingly inefficient. Adamantyl protection was achieved in high yield by refluxing the phosphinic acid, Ag2O, and 1-AdBr in chloroform. Subsequently a concise one-pot three-step reaction comprising a double deprotection of the N- and C-termini under catalytic hydrogenation conditions followed by selective protection of the N-terminus with an Fmoc group yielded Fmoc-NHCH2PO(OAd)CH2CH(2-butyl)CO2H in 41 % overall yield. These results indicate that, as the diversity of phosphinic pseudodipeptides is increased to create selective matrix metalloproteinase inhibitors, different synthetic pathways may be required for efficient building block preparation.

Entities:  

Keywords:  Matrix metalloproteinase; Peptidomimetic; Phosphinate; Protease; Protease inhibitor; Transition state analog

Year:  2012        PMID: 24496015      PMCID: PMC3564550          DOI: 10.1007/s10989-012-9307-y

Source DB:  PubMed          Journal:  Int J Pept Res Ther        ISSN: 1573-3149            Impact factor:   1.931


  22 in total

1.  Solid phase combinatorial library of phosphinic peptides for discovery of matrix metalloproteinase inhibitors.

Authors:  J Buchardt; C B Schiødt; C Krog-Jensen; J M Delaissé; N T Foged; M Meldal
Journal:  J Comb Chem       Date:  2000 Nov-Dec

2.  Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.

Authors:  Anastasios Makaritis; Dimitris Georgiadis; Vincent Dive; Athanasios Yiotakis
Journal:  Chemistry       Date:  2003-05-09       Impact factor: 5.236

Review 3.  Matrix metalloproteinases and collagen catabolism.

Authors:  Janelle L Lauer-Fields; Darius Juska; Gregg B Fields
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

Review 4.  Matrix metalloproteinase dependent and independent collagen degradation.

Authors:  Fengyu Song; Kessiri Wisithphrom; Jing Zhou; L Jack Windsor
Journal:  Front Biosci       Date:  2006-09-01

Review 5.  Matrix metalloproteinases as valid clinical targets.

Authors:  Barbara Fingleton
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides.

Authors:  Athanasios Yiotakis; Stamatia Vassiliou; Jirí Jirácek; Vincent Dive
Journal:  J Org Chem       Date:  1996-09-20       Impact factor: 4.354

Review 7.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

Authors:  Christopher M Overall; Oded Kleifeld
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

Review 8.  Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.

Authors:  Rajeshwar P Verma; Corwin Hansch
Journal:  Bioorg Med Chem       Date:  2007-01-17       Impact factor: 3.641

9.  Diastereoselective synthesis of alpha,beta'-disubstituted aminomethyl(2-carboxyethyl)phosphinates as phosphinyl dipeptide isosteres.

Authors:  Takehiro Yamagishi; Hiroyuki Ichikawa; Terumitsu Haruki; Tsutomu Yokomatsu
Journal:  Org Lett       Date:  2008-09-10       Impact factor: 6.005

10.  Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.

Authors:  Janelle L Lauer-Fields; Michael J Chalmers; Scott A Busby; Dmitriy Minond; Patrick R Griffin; Gregg B Fields
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

View more
  5 in total

1.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

2.  Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.

Authors:  Manishabrata Bhowmick; Roma Stawikowska; Dorota Tokmina-Roszyk; Gregg B Fields
Journal:  Chembiochem       Date:  2015-03-12       Impact factor: 3.164

3.  Characterization and regulation of MT1-MMP cell surface-associated activity.

Authors:  Sonia Pahwa; Manishabrata Bhowmick; Sabrina Amar; Jian Cao; Alex Y Strongin; Rafael Fridman; Stephen J Weiss; Gregg B Fields
Journal:  Chem Biol Drug Des       Date:  2018-12-19       Impact factor: 2.817

Review 4.  New strategies for targeting matrix metalloproteinases.

Authors:  Gregg B Fields
Journal:  Matrix Biol       Date:  2015-01-14       Impact factor: 11.583

Review 5.  Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.

Authors:  Gregg B Fields
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.